New study spotlights effective strategy against COVID-19 variants: the E7 monoclonal antibody
Researchers developed potent monoclonal antibodies from a severe acute respiratory syndrome coronavirus (SARS-CoV) survivor.
Source: news-medical.net
Stay updated with breaking news from Virus Neutralization Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers developed potent monoclonal antibodies from a severe acute respiratory syndrome coronavirus (SARS-CoV) survivor.